Search research articles
Contact Us
Filters
Showing results (61-70 of 107) with videos related to
Page
of 11
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1986
Interactions between endogenous dopamine and dopamine agonists at release modulatory receptors: multiple effects of neuronal uptake inhibitors on transmitter release
I S Hoffmann, R K Talmaciu, L X Cubeddu
Clinical Pharmacology and Therapeutics
|
April 1, 1987
Clinical pharmacology of doxazosin in patients with essential hypertension
L X Cubeddu, N Fuenmayor, N Caplan, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 1, 1988
Effects of amiloride and 5-(N,N-hexamethylene)amiloride on dopaminergic and cholinergic neurotransmission
J K Zubieta, E J Cragoe, L X Cubeddu
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 1979
Contribution of adrenal medulla, spleen and lymph, to the plasma levels of dopamine beta-hydroxylase and catecholamines induced by hemorrhagic hypotension in dogs
G Pinardi, R K Talmaciu, E Santiago, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 24, 1999
Use of intravenous microdialysis to monitor changes in serotonin release and metabolism induced by cisplatin in cancer patients: comparative effects of granisetron and ondansetron
A M Castejon, X Paez, L Hernandez, et al.
Journal of Cardiovascular Pharmacology
|
June 3, 2000
Effects of short- and long-term exercise on urinary cGMP excretion in healthy subjects and in patients with coronary artery disease
A B Alfieri, L G Rodriguez-Plaza, L X Cubeddu
Journal of Cardiovascular Risk
|
December 29, 1998
Urinary excretion of nitric oxide metabolites in runners, sedentary individuals and patients with coronary artery disease: effects of 42 km marathon, 15 km race and a cardiac rehabilitation program
L G Rodriguez-Plaza, A B Alfieri, L X Cubeddu
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 1994
Behavior of mesocortical dopamine terminals during single and repetitive stimulation: comparison with nigrostriatal neurons
E Agneter, I S Hoffmann, E A Singer, et al.
British Journal of Cancer
|
October 1, 1995
Plasma chromogranin A marks emesis and serotonin release associated with dacarbazine and nitrogen mustard but not with cyclophosphamide-based chemotherapies
L X Cubeddu, D T O'Connor, I Hoffmann, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1996
Differential effects of muscarinic receptor agonists and phorbol ester on muscarinic and D2-dopamine release-modulatory receptors
I S Hoffmann, R K Talmaciu, R Aquino, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 107) with videos related to
Sort By:
Page
of 11
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1986
Interactions between endogenous dopamine and dopamine agonists at release modulatory receptors: multiple effects of neuronal uptake inhibitors on transmitter release
I S Hoffmann, R K Talmaciu, L X Cubeddu
Clinical Pharmacology and Therapeutics
|
April 1, 1987
Clinical pharmacology of doxazosin in patients with essential hypertension
L X Cubeddu, N Fuenmayor, N Caplan, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 1, 1988
Effects of amiloride and 5-(N,N-hexamethylene)amiloride on dopaminergic and cholinergic neurotransmission
J K Zubieta, E J Cragoe, L X Cubeddu
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 1979
Contribution of adrenal medulla, spleen and lymph, to the plasma levels of dopamine beta-hydroxylase and catecholamines induced by hemorrhagic hypotension in dogs
G Pinardi, R K Talmaciu, E Santiago, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 24, 1999
Use of intravenous microdialysis to monitor changes in serotonin release and metabolism induced by cisplatin in cancer patients: comparative effects of granisetron and ondansetron
A M Castejon, X Paez, L Hernandez, et al.
Journal of Cardiovascular Pharmacology
|
June 3, 2000
Effects of short- and long-term exercise on urinary cGMP excretion in healthy subjects and in patients with coronary artery disease
A B Alfieri, L G Rodriguez-Plaza, L X Cubeddu
Journal of Cardiovascular Risk
|
December 29, 1998
Urinary excretion of nitric oxide metabolites in runners, sedentary individuals and patients with coronary artery disease: effects of 42 km marathon, 15 km race and a cardiac rehabilitation program
L G Rodriguez-Plaza, A B Alfieri, L X Cubeddu
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 1994
Behavior of mesocortical dopamine terminals during single and repetitive stimulation: comparison with nigrostriatal neurons
E Agneter, I S Hoffmann, E A Singer, et al.
British Journal of Cancer
|
October 1, 1995
Plasma chromogranin A marks emesis and serotonin release associated with dacarbazine and nitrogen mustard but not with cyclophosphamide-based chemotherapies
L X Cubeddu, D T O'Connor, I Hoffmann, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1996
Differential effects of muscarinic receptor agonists and phorbol ester on muscarinic and D2-dopamine release-modulatory receptors
I S Hoffmann, R K Talmaciu, R Aquino, et al.
Page
of 11